The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Telotristat ethyl to promote weight stability in patients with advanced pancreatic cancer.
 
Olumide Gbolahan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boston Scientific; Cardinal Health; Incyte; Lantheus Medical Imaging; Merus
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Elicio Therapeutics (Inst); EMD Serono (Inst); Jazz Pharmaceuticals (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Elham Babadi
No Relationships to Disclose
 
Tarrant McPherson
No Relationships to Disclose
 
Kathleen Coleman
No Relationships to Disclose
 
Jeffrey Switchenko
No Relationships to Disclose
 
Bassel El-Rayes
Honoraria - Charles River Associates
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis; Genentech; QED Therapeutics; Stemline Therapeutics; Taiho Oncology
Speakers' Bureau - Intellisphere
Research Funding - Adaptimmune (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); IQVIA (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Wayne State University (Inst); Xencor (Inst); Zymeworks (Inst)
Other Relationship - Erytech Pharma; Exelixis; SC Liver Research Consortium
 
Olatunji Alese
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; Exelixis; GlaxoSmithKline; Loxo/Lilly; Taiho Oncology; Takeda
Research Funding - Arcus Biosciences (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Ipsen (Inst); Pfizer (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Transcenta (Inst)
Other Relationship - COMPASS THERAPEUTICS, INC
 
Walid Shaib
No Relationships to Disclose